跳转至内容
Merck
CN

42000001

Sigma-Aldrich

PRONOVA® UP LVG

low viscosity sodium alginate, viscosity 20-200 mPa.s, 1 %(20 °C)(low), guluronate monomer units ≥60 %

别名:

Ultra-Pure Low Viscosity Gel

登录查看公司和协议定价

选择尺寸

关于此项目

UNSPSC代码:
12352201
NACRES:
NA.25

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

100

表单

powder

分子量

Mw 75-200 kDa (approximate)

组成

guluronate monomer units, ≥60%
G/M ratio, ≥1.5

杂质

≤100 CFU/g Total viable count
≤100 EU/g Endotoxins

pH值（酸碱度）

5.5-8.5 (20 °C, 1% in water)

粘度

20-200 mPa.s, 1 %(20 °C) (
low)

一般描述

PRONOVA UP LVG is a low viscosity (20-200 mPas) sodium alginate where minimum 60% of the monomer units are guluronate.

应用

Examples of Pronova UltraPure Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.

法律信息

Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.

免责声明

NOT FOR USE IN HUMANS

储存分类代码

11 - Combustible Solids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持